Do you want to read an article? Please log in or register.
Emergence of bedaquiline-resistance in a high-burden country of tuberculosis
Tuberculosis
RECOMMENDED
Related content
RECOMMENDED
Tuberculosis
Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Chesov D, Heyckendorf J, Alexandru S, Donica A, Chesov E, Reiman M, Crudu V, Botnaru V, Lange C
doi: 10.1183/13993003.02544-2020
Clinical Management of Multidrug-resistant Tuberculosis in 16 European Countries
Am J Respir Crit Care Med.
Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Magis-Escurra C, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C
doi: 10.1164/rccm.
Tuberculosis
Bedaquiline or delamanid for rifampin-resistant tuberculosis?
Lancet Respir Med.
Lessem E, Cox V, Furin J
RECOMMENDED
Tuberculosis
Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Res
Teo AKJ, Singh SR, Prem K, Hsu LY, Yi S
doi: 10.1186/s12931-021-01841-6
RECOMMENDED
Tuberculosis
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
Lancet Infect Dis.
Knight GM, McQuaid CF, Dodd PJ, Houben RMGJ
doi: 10.1016/S1473-3099(19)30307-X.
RECOMMENDED
Tuberculosis
Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Glob Health.
Yuen CM, Seddon JA, Keshavjee S, Dodd PJ
doi: 10.1016/S2214-109X(20)30075-9.
RECOMMENDED
Tuberculosis
All-oral longer regimens are effective for the management of multidrug resistant tuberculosis in high burden settings
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Khan PY, Franke MF, Hewison C, Seung KJ, Huerga H, Atwood S, Ahmed S, Khan M, Sultana T, Manzur-Ul-Alam M, Vo LNQ, Lecca L, Yae K, Kozhabekov S, Tamirat M, Gelin A, Vilbrun SC, Kikvidze M, Faqirzai J, Kadyrov A, Skrahina A, Mesic A, Avagyan N, Bastard M, Rich ML, Khan U, Mitnick CD
doi: 10.1183/13993003.04345-2020
RECOMMENDED
Tuberculosis
Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med.
Mishra H, Reeve BWP, Palmer Z, Caldwell J, Dolby T, Naidoo CC, Jackson JG, Schumacher SG, Denkinger CM, Diacon AH, van Helden PD, Marx FM, Warren RM, Theron G
doi: 10.1016/S2213-2600(19)30370-4.
RECOMMENDED
Tuberculosis
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
Emerg Infect Dis.
Mbuagbaw L, Guglielmetti L, Hewison C, Bakare N, Bastard M, Caumes E, Fréchet-Jachym M, Robert J, Veziris N, Khachatryan N, Kotrikadze T, Hayrapetyan A, Avaliani Z, Schünemann HJ, Lienhardt C
doi: 10.3201/eid2505.181823.